共有 50 笔近期内部人交易记录记录，涉及 Becton, Dickinson and Company (BDX), 包括 28 笔买入 和 15 笔卖出. 内部人买入总额为 RSU 奖励 内部人卖出总额为 $918.06K.
近期活跃的重要内部人包括 Neal Shana Carol, Feld Michael, Minnix Lanesha. 内部人交易记录可以揭示公司管理层对股票估值和未来前景的看法.
内部人交易记录 — BDX
| 日期 |
姓名 |
职位 |
交易类型 |
股数 |
平均价格 |
总价值 |
持股数量 |
| 2026-04-06 |
Neal Shana Carol |
EVP and Chief People Officer |
RSU 预扣税 |
1,146 |
- |
- |
23,966 |
| 2026-03-26 |
Feld Michael |
EVP, Chief Revenue Officer |
知情卖出 |
75 |
$156.83 |
$11.76K |
21,233 |
| 2026-03-16 |
Minnix Lanesha |
EVP and General Counsel |
未知 |
- |
- |
- |
- |
| 2026-03-16 |
Minnix Lanesha |
EVP and General Counsel |
限制性股票授予 (RSU) |
7,492 |
- |
- |
7,492 |
| 2026-03-02 |
Spikner Pamela L. |
SVP Controller & CAO |
限制性股票授予 (RSU) |
931 |
- |
- |
3,323 |
| 2026-03-02 |
Roque Vitor |
Interim CFO |
限制性股票授予 (RSU) |
931 |
- |
- |
6,510 |
| 2026-02-26 |
Feld Michael |
EVP, Chief Revenue Officer |
知情卖出 |
75 |
$181.84 |
$13.64K |
21,308 |
| 2026-02-18 |
Scott Bertram L |
Director |
知情卖出 |
953 |
$182.61 |
$174.03K |
36,763 |
| 2026-02-04 |
Jones Christopher Ian Montague |
Director |
限制性股票授予 (RSU) |
272 |
- |
- |
11,649 |
| 2026-02-04 |
Huffines Robert Luther |
Director |
限制性股票授予 (RSU) |
100 |
- |
- |
100 |
| 2026-02-04 |
Byington Carrie L |
Director |
限制性股票授予 (RSU) |
30 |
- |
- |
1,714 |
| 2026-02-01 |
Urbini Massimiliano |
EVP & Chief Isc Officer |
未知 |
- |
- |
- |
4,133 |
| 2026-01-27 |
Ring Timothy M |
Director |
限制性股票授予 (RSU) |
1,098 |
- |
- |
59,160 |
| 2026-01-27 |
Eckert R Andrew |
Director |
限制性股票授予 (RSU) |
1,098 |
- |
- |
10,423 |
| 2026-01-27 |
Scott Bertram L |
Director |
限制性股票授予 (RSU) |
1,098 |
- |
- |
37,716 |
| 2026-01-27 |
Hayes Gregory |
Director |
限制性股票授予 (RSU) |
1,098 |
- |
- |
7,159 |
| 2026-01-27 |
Jones Christopher Ian Montague |
Director |
限制性股票授予 (RSU) |
1,098 |
- |
- |
24,304 |
| 2026-01-27 |
Henderson Jeffrey William |
Director |
限制性股票授予 (RSU) |
1,098 |
- |
- |
9,143 |
| 2026-01-27 |
Brown William M |
Director |
限制性股票授予 (RSU) |
1,098 |
- |
- |
4,663 |
| 2026-01-27 |
Huffines Robert Luther |
Director |
限制性股票授予 (RSU) |
1,098 |
- |
- |
1,279 |
| 2026-01-27 |
Wright Jacqueline |
Director |
限制性股票授予 (RSU) |
1,098 |
- |
- |
1,279 |
| 2026-01-27 |
Byington Carrie L |
Director |
限制性股票授予 (RSU) |
1,098 |
- |
- |
5,018 |
| 2026-01-27 |
Waldstreicher Joanne |
Director |
限制性股票授予 (RSU) |
1,098 |
- |
- |
3,391 |
| 2026-01-26 |
Feld Michael |
EVP, Cro & Pres. Life Sciences |
知情卖出 |
75 |
$202.73 |
$15.2K |
16,431 |
| 2026-01-21 |
Spikner Pamela L. |
SVP Controller & CAO |
RSU 预扣税 |
84 |
- |
- |
1,832 |
| 2026-01-15 |
Garrison Michael David |
EVP & Pres Med.essntl&biopharm |
期权行权（卖出） |
3,054 |
$167.91 |
$512.8K |
- |
| 2026-01-03 |
Shan David |
EVP and Chief Isc Officer |
RSU 预扣税 |
44 |
- |
- |
8,926 |
| 2025-12-26 |
Feld Michael |
EVP, Cro & Pres. Life Sciences |
知情卖出 |
74 |
$196.08 |
$14.51K |
16,506 |
| 2025-12-17 |
Garrison Michael David |
EVP & Pres Med.essntl&biopharm |
知情卖出 |
629 |
$196.03 |
$123.3K |
13,105 |
| 2025-12-05 |
Roque Vitor |
Interim CFO |
未知 |
- |
- |
- |
4,477 |
| 2025-12-01 |
Huffines Robert Luther |
Director |
未知 |
- |
- |
- |
- |
| 2025-12-01 |
Huffines Robert Luther |
Director |
限制性股票授予 (RSU) |
180 |
- |
- |
180 |
| 2025-12-01 |
Wright Jacqueline |
Director |
未知 |
- |
- |
- |
- |
| 2025-12-01 |
Wright Jacqueline |
Director |
限制性股票授予 (RSU) |
180 |
- |
- |
180 |
| 2025-12-01 |
Feld Michael |
EVP, Cro & Pres. Life Sciences |
知情卖出 |
75 |
$193.36 |
$14.5K |
16,580 |
| 2025-11-26 |
Urbini Massimiliano |
EVP & Chief Isc Officer |
未知 |
1,984 |
$224.25 |
$444.91K |
- |
| 2025-11-26 |
Polen Thomas E Jr |
Chairman, CEO and President |
RSU 预扣税 |
17,421 |
- |
- |
105,471 |
| 2025-11-26 |
Goette Roland |
EVP and President, Emea |
限制性股票授予 (RSU) |
1,906 |
- |
- |
16,123 |
| 2025-11-26 |
Muhsin Bilal |
EVP & President Connected Care |
限制性股票授予 (RSU) |
9,530 |
- |
- |
21,751 |
| 2025-11-26 |
Neal Shana Carol |
EVP and Chief People Officer |
限制性股票授予 (RSU) |
6,727 |
- |
- |
20,255 |
| 2025-11-26 |
Delorefice Christopher |
EVP & Chief Financial Officer |
RSU 预扣税 |
4,245 |
- |
- |
22,982 |
| 2025-11-26 |
Mocherla Pavan Kumar |
EVP & President, Greater Asia |
限制性股票授予 (RSU) |
2,208 |
- |
- |
5,055 |
| 2025-11-26 |
Garrison Michael David |
EVP & Pres Med.essntl&biopharm |
限制性股票授予 (RSU) |
7,568 |
- |
- |
12,455 |
| 2025-11-26 |
Byrd Richard |
EVP & President Interventional |
限制性股票授予 (RSU) |
6,447 |
- |
- |
13,183 |
| 2025-11-26 |
Shan David |
EVP and Chief Isc Officer |
限制性股票授予 (RSU) |
3,504 |
- |
- |
8,079 |
| 2025-11-26 |
Spikner Pamela L. |
Svpcontroller & Chief Acct Off |
限制性股票授予 (RSU) |
1,234 |
- |
- |
1,916 |
| 2025-11-26 |
Feld Michael |
EVP, Cro & Pres. Life Sciences |
RSU 预扣税 |
419 |
- |
- |
16,655 |
| 2025-11-26 |
Roque Vitor |
Interim CFO |
未知 |
1,849 |
$224.25 |
$414.64K |
- |
| 2025-11-07 |
Scott Bertram L |
Director |
知情卖出 |
217 |
$176.58 |
$38.32K |
35,816 |
| 2025-11-04 |
Jones Christopher Ian Montague |
Director |
限制性股票授予 (RSU) |
168 |
- |
- |
11,316 |
■ 知情交易 — 公开市场买卖（最具参考价值）
■ 非知情买入 — 奖励、期权行权、转换
■ 非知情卖出 — 税务代扣、归属出售
■ 中性 — 礼赠、信托、到期
